|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
We measured the end-tidal plateau in exhaled NO concentration (CETNO) by chemiluminescence and
calculated the product of
E and CETNO (
NO) in nine healthy subjects at rest and during three intensities of cycling exercise (30%, 60%, and 90%
O2max), two levels of hyperventilation (
E = 42.8 ± 9.1 L/min and 84.2 ± 6.6 L/min), and during breathing of hypoxic gas mixtures (five subjects, FIO2 = 14%) at rest and during exercise at 90%
O2max. Immediately after each trial we also measured exhaled [NO] at constant expiratory flow rates ([NO]CF) of 46 ml/s and 950 ml/s, utilizing added expiratory resistance to increase mouth pressure and close the velum (Silkoff and colleagues, Am. J. Respir.
Crit. Care Med. 1997;155:260). CETNO decreased and
NO increased above resting levels with increasing exercise intensity during hyperventilation and during hypoxic exercise (p < 0.05). [NO]CF, measured at either 46 ml/s or 950 ml/s, did not increase under any of the conditions investigated (exercise, hyperventilation, or hypoxia). Venous blood from seven of the subjects was sampled for the
measurement of plasma [NO3
]. Resting plasma [NO3
] averaged 42.5 ± 14.7 µmol/L, with no
change during exercise, hyperventilation, or hypoxia. On the basis of these results we conclude that
reported increases in
NO do not reflect an exercise-induced augmentation of systemic and/or airway
NO production. Rather, the increases in
NO during exercise or hyperventilation are a function of
high airflow rates, which reduce the luminal [NO]. This decreases the concentration gradient for NO
between the alveolar space and pulmonary capillary blood, which results in a decrease in the fraction
of NO taken up by the blood and an increase in the volume of NO recovered in the exhaled air (
NO).
St. Croix CM, Wetter TJ, Pegelow DF, Meyer KC, Dempsey JA. Assessment of nitric oxide formation during exercise.
| |
INTRODUCTION |
|---|
|
|
|---|
Endogenous nitric oxide (NO) is detectable in expired air (1),
and its "production" (
NO, the product of exhaled NO concentration [NO] and minute ventilation [
E]) has been shown
to increase during exercise (2). However, the origin and
physiologic significance of the increase is unresolved. It has
been proposed that the increase in NO exhalation during exercise is linked to the increase in cardiac output (CO) (2, 3, 5)
and resulting increase in shear stress to the pulmonary vascular endothelium. The reported increases in the levels of nitrate
and nitrite (NO3
and NO2
), the stable end-products of NO
metabolism, in venous blood after a single session of prolonged exercise, suggest that exercise augments the vascular
production of NO (8). However, given the rapid uptake and
inactivation of NO by hemoglobin (9), it is unlikely that
changes in systemic and/or pulmonary vascular formation of NO
would be detectable in the expirate. Alternatively, it has been
proposed that the increased
NO during exercise reflects a
rise in NO production by airway epithelial cells related to increased or turbulent airflow (6, 7). Although the effects on epithelial NO production of increased airflow through the airways are not known, it has recently been shown that both
exhaled [NO] and
NO depend on the rate of airflow (10). In
fact, it has been postulated that the changes in
E alone during exercise may explain the changes in
NO (6, 7, 10). This is
supported by the finding that resting hyperventilation also induces an increase in
NO (4, 6, 7).
Previous studies of exhaled NO production during exercise
(2) have not controlled for the effects of changes in flow
rate on [NO] and
NO (10). In addition, high concentrations of
NO in the expirate may reflect contamination with nasal NO if
the velum is open during any part of the exhalation (10). The
nasal contribution to total exhaled [NO] has been reported to
exceed 50% at rest, and to be as high as 30% during exercise
(7). Accordingly, we questioned whether the increase in
NO
with exercise represented increased NO production by the
systemic or pulmonary vasculature or by the airway epithelium, or whether the increased
NO was merely the result of
an increased expiratory flow rate and clearance from the lung.
The purpose of this study was therefore to accurately assess
the effect of exercise on endogenous NO formation by measuring exhaled [NO] at a constant airflow rate, using an added
expiratory resistance to increase mouth pressure and close the
velum (10). We also examined the concentrations of nitrate and nitrate [NO3
+ NO2
] (stable end-products of NO metabolism) in venous plasma as an index of endogenous NO formation.
| |
METHODS |
|---|
|
|
|---|
Nine healthy, nonasthmatic, nonsmoking subjects (six males and three
females) aged 27 to 59 yr and of widely varying fitness levels (
O2max
26.8 to 68.0 ml/kg/min), participated in the study. All procedures were
approved by the Institutional Review Board of the University of Wisconsin-Madison. Subjects were instructed to maintain a nitrate/nitrite-restricted diet during the 24 h before sampling for nitrate in plasma.
Exhaled [NO] was measured with a rapid-response (< 200 ms for
90% of full scale) chemiluminescence analyzer (Model 280 NOA;
Sievers, Boulder, CO). Calibration of the analyzer was done before
each experiment, using NO-free air and a certified gas mixture containing NO at 45 ppm (Scott Specialty Gases, Troy, MI). The subjects
breathed ambient air in which [NO] was less than 5 ppb during all trials. For the breath-by-breath measurements, subjects breathed through
a low-resistance, two-way valve (Model 2700; Hans Rudolph, Kansas
City, MO), with the nose occluded. CO2 and O2 were sampled at the
mouth and from a mixing chamber (8.64 L) via a mass spectrometer
(Model 1100; Perkin-Elmer, Norwalk, CT). Inspiratory and expiratory
flow rates were measured separately with pneumotachographs. All signals were displayed on a chart recorder, sent through an analog-to-digital board, and sampled on a computer at 75 Hz.
NO has been calculated through either mixed expired (4) or
end-expiratory (2, 3) sampling of NO. During tidal breathing, the profile of expired [NO] is characterized by an early peak during the first
part of exhalation, followed by a plateau in [NO] (see Figure 1 in Reference 6). To calculate
NO, we chose to use the plateau in exhaled
[NO] concentration measured at the mouth during the last part of
each tidal breath (CETNO). We felt that this plateau value was more
likely to reflect NO produced in the lungs (and/or conducting airways)
than were measurements of mixed expired NO (CENO). There is considerable evidence for a substantial nasal contribution to exhaled
[NO] during tidal breathing, even with noseclips in place (7, 10). The
source of the early peak in the profile of exhaled [NO] measurement
made without resistance (to close the soft palate) is probably the nasal
passages rather than the lungs or conducting airways (10). Therefore,
mixed expired measurements are likely to contain NO from both nasal and pulmonary sources. However, in order to conform our study
with previous studies of exercise effects on
NO (4, 6, 7), we also measured both mixed expired [NO] (via continuous sampling from the
mixing chamber) and end-tidal [NO] in five of the nine subjects during each of the experimental protocols.
|
Venous blood samples (3 ml) were collected in heparinized tubes
and centrifuged for separation of plasma. The plasma samples were
kept frozen until analysis. Plasma was deproteinized through cold ethanol precipitation. To measure NO3
, vanadium (III) chloride in 1 M
HCl was used to convert NO3
to NO. Vanadium (III)/HCl will also
convert NO2
and S-nitrosoproteins to NO. To achieve a high conversion efficiency, the reduction was run at 90° C. Helium was used to
purge NO from solution, resulting in a peak of NO for measurement
by chemiluminescence (Model 280 NOA; Sievers). Calibration curves
based on standard solutions ranging from 5 to 200 µM NO3
were
constructed daily.
Protocol
Resting data were collected over a 5-min period prior to each of the
exercise, hyperventilation, and hypoxia trials. All nine subjects completed 3 min of constant-load cycle ergometric exercise at three different exercise intensities corresponding to 30% (516 ± 168 kpm), 60%
(883 ± 229 kpm), and 90%
O2max (1,328 ± 374 kpm). Eight of the
subjects also completed 3 min of resting voluntary hyperventilation at
two different levels (f = 20 breaths/min and 40 breaths/min, VT = 2L,
and TI/Ttot = 0.5). Isocapnia was maintained during hyperventilation
by bleeding CO2 into the inspiratory limb of the breathing circuit. Five
of the subjects were also studied during resting hypoxia (FIO2 = 14%)
and hypoxic exercise at 90%
O2max. The respiratory variables, including CETNO and CENO, were averaged over the last 30 s of each
resting, exercise, and hyperventilation trial.
NO was calculated as the
product of CETNO or CENO (ppb) and
E (L/min, STPD), and was
expressed in nl/min (10
9 × L/min). In seven of the subjects, blood was
sampled from a cubital vein over the last 20 s of each trial for the measurement of nitrates and nitrites in plasma.
Exhaled [NO] was measured in all subjects via a sideport close to the mouth, at a constant expiratory airflow rate of 46 ml/s ([NO]CF), using the methods described by Silkoff and colleagues (10). Subjects breathed through a mouthpiece (without noseclips) against an added expiratory resistance in order to close the velum and eliminate nasal NO from the exhalate. Five of the nine subjects performed this maneuver at two expiratory flow rates (46 ml/s and 950 ml/s), which were produced by using different resistances placed in the expiratory limb of the breathing circuit. The high expiratory flow rate (950 ml/s) was created with a short section of glass tubing with an internal diameter of 4.5 mm. The low expiratory flow rate (46 ml/s) was created with a standard 16-gauge medical needle. Within 5 s after the termination of either hyperventilation or exercise, subjects inhaled (via the mouth) to TLC and then exhaled (via the mouth) against the added expiratory resistance. During the expiration, subjects were instructed, through a visual display on the computer monitor, to maintain a constant mouth pressure of 20 mm Hg. The plateau (> 10 s for the low expiratory flow rate and averaging 3 s for the high expiratory flow rate) in the measured NO concentration was defined as [NO]CF. Duplicate resting [NO]CF measurements for each subject showed good reproducibility, with the mean difference between measurements averaging 1.1 ± 0.8 ppb (or 2.3 ± 2.3% of the absolute mean value) at an expiratory flow rate of 46 ml/s, and 0.04 ± 0.17 ppb (1.6 ± 1.7%) at a flow rate of 950 ml/s (p > 0.1). [NO]CF was also measured during the last 30 s of moderate exercise in five of the nine subjects.
Analysis
All data are expressed as means ± SD. The variations in
E, CETNO,
CENO,
NO, and [NO]CF over the range of exercise intensities and
levels of hyperventilation were examined through analysis of variance
(ANOVA) for repeated measures. When differences were obtained,
post hoc analyses were done with Bonferroni's t test. Significance was
set at p < 0.05.
| |
RESULTS |
|---|
|
|
|---|
Exhaled NO during Exercise
The components of the calculated
NO parameter are
E and
CETNO. In all subjects,
E increased (Figure 1A) and CETNO
(Figure 1B) decreased progressively (p < 0.05, Table 1) from
rest to heavy exercise, whereas
NO showed a progressive
increase (p < 0.05) from rest to heavy exercise (Table 1, Figure 2C).
|
|
When measured at a constant expiratory airflow rate of 46 ml/s, exhaled [NO] ([NO]CF) showed no increase immediately
after exercise (Table 1, Figure 1D). In fact, in all nine subjects there was a small but significant (p < 0.05) decrease in [NO]CF (
3.4 ± 3.0 ppb) from rest to mild exercise, with no difference between exercise levels. These measurements of [NO]CF were
made on the first breath after each trial, owing to subjects' difficulty in maintaining a constant mouth pressure during heavy
exercise. However, five of the subjects were able to perform
this maneuver during the final 30 s of moderate exercise. In
these subjects, there was no difference between [NO]CF measured at rest (16.7 ± 3.8 ppb), during cycling at 60%
O2max
(15.5 ± 5.6 ppb), or on the first breath after exercise (16.0 ± 4.7 ppb). Exhalation time decreased progressively from rest
(28.1 ± 2.5 s) to heavy exercise (17.0 ± 6.1 s). However, in all
cases, subjects were able to maintain a constant expiratory
flow rate of 20 mm Hg, and exhaled [NO] reached a plateau
within 5 to 12 s. [NO] measurements made at equivalent time
points during the exhalation gave values equal to the plateau value.
Exhaled NO during Voluntary Hyperventilation
In the eight subjects who completed the voluntary hyperventilation trials, CETNO decreased (p < 0.05) with the increase in
E (Figure 2A, Table 1).
NO showed a tendency to increase with increasing
E in five of the eight subjects (Figure 2B), but increases in the group mean values only reached significance during heavy hyperventilation at 80 L/min (Table 1).
When measured at a constant expiratory airflow rate of 46 ml/s,
there was no change in exhaled [NO] ([NO]CF) after hyperventilation (Figure 2C, Table 1).
Exhaled NO during Hypoxia
Five of the subjects participated in the hypoxic trials. During
resting hypoxia, SaO2 dropped to 93.2 ± 1.5% (PETO2 = 68.2 ± 8.1 mm Hg).
E (13.8 ± 1.4 L/min) was not significantly increased above its levels during breathing of room air (12.9 ± 3.3 L/min), and CETNO,
NO, and [NO]CF during hypoxia were
also not different from their normoxic resting levels (Table 2,
Figure 3). During hypoxic exercise at 90%
O2max, SaO2 fell
to 85.4 ± 5.0% (PETO2, 69.3 ± 2.9 mm Hg) and
E increased
by 24.3 ± 13.2 L/min (p < 0.05) over its value during breathing of room air at the same workload (Figure 3A). CETNO decreased to 3.1 ± 2.3 ppb during hypoxic exercise from 9.9 ± 6.8 ppb during hypoxic rest (Figure 3B), but the difference in
CETNO between normoxic exercise and hypoxic exercise
(
0.7 ± 1.0 ppb) was not significant.
NO increased significantly above its resting levels during hypoxic exercise (Table 2,
Figure 3C).
NO during hypoxic exercise was increased above its
levels during normoxic exercise in four of five subjects, but the
group mean difference (+13.4 ± 29.9 nl/min) was not significant (p > 0.05). When exhaled [NO] ([NO]CF) was measured
at a constant expiratory airflow rate, there was no change from
its resting levels after hypoxic exercise (Table 2, Figure 3D).
|
|
Comparison of Mixed Expired [NO] with End-Tidal [NO]
Under all conditions, CENO was significantly higher (p < 0.05) than CETNO (Table 3). However, CENO showed the
same tendency to decrease progressively from rest to heavy
exercise and during hyperventilation as did CETNO (Table 3).
NO calculated with CENO was also significantly greater (p < 0.05) than
NO calculated with CETNO, but showed the same
tendency to increase during hyperventilation (112.5 ± 88.6%
increase with the use of CENO, and 63.8 ± 66.2% increase
with CETNO), as well as with increasing exercise intensity (120.3 ± 55.0% increase from rest to heavy exercise using
CENO, and 56.7 ± 45.2% increase using CETNO).
|
Measurements of Exhaled [NO] at Constant Low (46 ml/s) and High (950 ml/s) Expiratory Flow Rates
Under all conditions, measurements of exhaled [NO] made at
a constant expiratory flow rate of 950 ml/s on the same five
subjects described earlier gave significantly lower values (p < 0.05) than measurements made with these five subjects at a
constant flow rate of 46 ml/s (Table 4). Hyperventilation had
no effect on exhaled [NO] measured at either expiratory flow
rate (Table 4). There was also no exercise-induced increase in
exhaled [NO] measured at either the low (46 ml/s) or high
flow rate (950 ml/s). In fact, at both expiratory flow rates,
there was a small but significant (p < 0.05) decrease in exhaled [NO] from rest to mild exercise, with no difference between exercise levels (Table 4). In the five subjects on whom
the measurements were made, [NO]CF measured at either the
low or high flow rate was also significantly below its levels
during rest following hypoxic exercise at 90%
O2max (Table
4). There was no difference between [NO]CF measured at a
constant expiratory flow rate of 950 ml/s during the last 30 s of
cycling at 60% VO2max (3.1 ± 1.8 ppb) and [NO]CF measured in the first breath following the cycling exercise (3.1 ± 1.7 ppb).
|
[NO3
+ NO2
] in Plasma
Resting plasma [NO3
+ NO2
] averaged 42.5 ± 14.7 µmol/L,
and showed no change during exercise (Table 1, Figure 4A) or
voluntary hyperventilation (Table 1, Figure 4B). In the five
subjects who completed the hypoxic trials, resting normoxic
plasma [NO3
+ NO2
] averaged 36.1 µmol/L with no change
from normoxic values during hypoxia at rest (39.5 ± 17.5 µmol/L) or during exercise at 90%
O2max (36.2 ± 10.9 µmol/L) (Table 2, Figure 4C).
|
| |
DISCUSSION |
|---|
|
|
|---|
Our aim was to determine the effect of exercise on exhaled
NO and NO production when the expiratory flow rate was
standardized and nasal contributions to the exhaled gas were
eliminated. We used a validated technique (10) for measuring
exhaled NO that: (1) prevented nasal contamination of exhaled pulmonary gas; and (2) had the subject maintain a constant expiratory flow, thus preventing variation in exhaled NO
caused by changes in airflow rate. Using this technique, we
showed that the NO concentration in exhaled air was not increased by exercise, hyperventilation during rest, or hypoxia,
and concluded that if there was an exercise-induced augmentation of endogenous NO formation, it was not detectable in
the exhaled air. Therefore, the increase in
NO during exercise resulted from the concomitantly increased airflow through the lungs, and did not reflect enhanced pulmonary vascular and/or airway epithelial NO formation.
Source of Exhaled [NO]
In the intact human, the precise origins of exhaled NO remain unknown. It has been shown that exhaled [NO] decreases after the administration of NO synthase (NOS) inhibitors (1, 11), suggesting that NO is produced endogenously in the lungs. Measurements of expired gas and lung effluent in buffer-perfused isolated rabbit lungs also demonstrated that NO is released by the lung and diffuses into both the alveolar space and the intravascular compartment (12). The expired NO could originate in the airways, where it is produced in the epithelial cells and neurons lining the bronchial wall, or in the alveolus, where it could be derived from the cells in the alveolar wall or from NO delivered to the alveolus by pulmonary blood flow (13).
The decrease in exhaled NO concentration and increase in
NO that occur during exercise have been well documented
(2, 6, 7), and our data are in close agreement with these results. This exercise-induced decrease in exhaled [NO] and increase in
NO during tidal breathing was observed both with
mixed expired and end-tidal plateau measurements of [NO].
The increase in calculated
NO has been interpreted to reflect
increased NO production in the pulmonary vasculature,
caused by the increase in CO during exercise and the resulting
changes in endothelial shear stress (2, 5, 14). Although it has
been shown that both increases in blood flow and the introduction of pulsatile flow augment endothelial NO production
in perfused canine femoral artery segments (15), recent attempts to modify pulmonary blood flow in humans, using water immersion and increased gravity (16), or dobutamine infusion (7) to increase CO, have failed to alter the
NO measured in exhaled air at rest or during exercise. In fact, it is unlikely that an increase in systemic and/or pulmonary vascular endothelial NO release could actually be detected in exhaled NO,
given the short half-life of NO in physiologic systems (13) and
the high affinity of NO for oxyhemoglobin (9).
The increased
NO observed during exercise has also been
interpreted to indicate increased NO production in airway epithelial cells, caused by increased and/or turbulent airflow (6,
7). However, even if NO production in the airways is augmented during exercise, this may not be reflected in the expired gas. Because of the high diffusing capacity of the lungs
for NO, a large fraction of the NO produced by the lungs will
be transported into the pulmonary capillary blood (17). In the
blood, NO binds rapidly to reduced hemoglobin to be converted to methemoglobin, and reacts with the cysteine residues of the
-subunits of hemoglobin to produce S-nitrosothiols (9). Thus, the partial pressure of NO in the capillaries is extremely low, and the concentration gradient between the
cells lining the airway and the capillary blood is high. It has
been estimated that 94% of the NO produced in the lower
airways diffuses into blood, whereas the remaining 6% will
diffuse into the airway lumen to be exhaled (17). Recent
mathematical models developed by Hyde and colleagues (17)
predict that if NO production in the airways remains constant
during exercise, the luminal concentration of NO will decrease
because of large increases in expiratory airflow rates, which
reduce contact time between the airway wall and the exhaled
air (10). This will reduce the concentration gradient for NO
between the alveolar space and the pulmonary capillary blood,
resulting in a decrease in the fraction of NO taken up by the
blood and an increase in the volume of NO recovered in the
exhaled air (
NO). Thus, exercise may not necessarily increase NO release by airway epithelial cells, but may merely shift the rate of elimination of a fraction of the total NO production from the alveolar capillary blood to the expired gas, owing largely to
increases in alveolar ventilation (17). Similarly, Massaro and
Drazen (18) theorized that the number of moles of NO produced in the airways per unit time actually remains unchanged
during exercise, and that the increase in the calculated
NO
parameter represents a dynamic equilibrium between the production of NO in the lung and the diffusion of NO into the airway lumen, or its interaction with biologic "sinks" in the blood.
Our study tested these theories directly by measuring exhaled [NO] at a constant expiratory airflow rate. We used two
markedly different airflow rates to differentiate between alveolar and airway sources of exhaled NO. It has been suggested
that alveolar [NO] is best estimated with a rapid exhalation
(10). At a high flow rate of 950 ml/s, the NO from the airways
would be greatly diluted by the large volume of air coming
from the alveoli, whereas at a low flow rate of 46 ml/s, the contact time between the air and the bronchial wall is increased
and there is much less dilution by alveolar air of the NO produced in airway epithelial cells. Therefore, at a flow rate of 46 ml/s, the major source of exhaled NO is the conducting airways. We showed that when the expiratory airflow rate was
held constant at either 46 ml/s or 950 ml/s, the exhaled NO
concentration did not increase above resting levels from mild
through near maximal exercise in subjects of widely varying
fitness levels. Thus, if vascular and/or airway epithelial NO
production was increased by exercise, it was not detectable in
exhaled breaths, whether they primarily reflected NO release at the level of the alveolar-capillary interface (950 ml/s) or NO release from the airway epithelium (46 ml/s). These results demonstrated, as was previously theorized (10, 17, 18), that it was actually the increased airflow rates experienced
during exercise that caused the decrease in exhaled [NO] measured in breath-by-breath analysis and the increase in calculated
NO. As would be predicted on the basis of these theories, we also observed an increase in calculated
NO during
voluntary hyperventilation, but no change in exhaled [NO]
when the expiratory airflow rate was held constant (on the
first breath after hyperventilation). Even when we imposed
hypoxia, and presumably increased pulmonary blood flow and
hypoxia-induced pulmonary vasoconstriction (19) during very
heavy exercise, we saw no change in exhaled [NO] measured at a constant expiratory airflow rate.
We did observe a small but significant decrease below preexercise resting levels in the exhaled [NO] measured at a constant expiratory flow rate ([NO]CF) on the first breath immediately after exercise. We do not believe that this change was due to differences in measurement techniques. All subjects were carefully instructed to inhale to TLC and to immediately exhale via the mouth. Mouth pressure and airflow rate were displayed and monitored throughout the exhalation to ensure that they did not deviate from the chosen values of 20 mm Hg and 46 ml/s (or 950 ml/s), respectively. It was recently reported that exhaled [NO] (also measured at a constant expiratory flow rate) was significantly decreased below resting levels at 10 min after a marathon (20). It was suggested this decrease might have reflected suppressed immune function after strenuous exercise. In five of our subjects, additional measurements made 5 to 10 min into the recovery period after exercise (data not shown), showed that exhaled [NO] had risen to preexercise resting levels. We believe that our findings may be explained by the model proposed by Hyde and colleagues (17) to describe the factors altering the observed [NO] exhaled from the airways. On the basis of this model, the decrease in [NO]CF on the first breath after exercise may not necessarily reflect a change in NO production in the airways, but may indicate that a greater fraction of the total NO produced in the epithelial cells is taken up by the pulmonary capillary blood because of increases in the diffusing capacity of the lung for NO during exercise. During recovery, as cardiac output and diffusing capacity decrease, the exhaled [NO]CF would be expected to increase to preexercise values.
It has recently been suggested that NO production by the alveoli and by the conducting airways can be estimated for each of these loci by using measurements of exhaled [NO] made at different constant expiratory flow rates (21). Accordingly, we applied our data, listed in Table 4, to this model, which uses the calculated slope and intercept of the relationship between expiratory flow rate and exhaled volume of NO per minute to estimate the contribution of alveolar and airway sources of NO, respectively, to total elimination of NO by the lung. As expected, these calculations showed that neither alveolar nor airway NO production was increased by exercise or hyperventilation.
Measurement of Plasma [NO3
+ NO2
]
Endothelial release of NO is a function of vascular shear stress
(15), which is increased in both the pulmonary and systemic vasculature during exercise by the augmentation of CO. Other
potential endogenous sources of NO during exercise include
skeletal muscle (22) and nitroxidergic nerves (23). We saw no
change in the measured levels of nitrate plus nitrite in venous
plasma during mild to very heavy exercise. In agreement with
these findings, others have also shown no change in these end
products of NO metabolism following an incremental treadmill test to exhaustion in healthy human subjects (24, 25). In
contrast, it has also been reported that [NO3
+ NO2
] is increased in venous plasma after prolonged running or cycling exercise (8) and after incremental cycling exercise to
O2max (26). Although the source of these discrepant results is not clear, there were differences in the duration and intensity of the exercise protocols used. The periods of moderate exercise used by Jungersten and colleagues (8) were markedly longer (at over 2 h) than either our total of 9 min of cycling exercise or the periods of incremental treadmill exercise to
O2max,
which averaged about 15 min (24, 25). The selection of an older subject group (mean age: 60 yr) by Node and coworkers (26)
may have influenced their results, in view of reports of age-related increases in serum nitrate levels (24).
We doubt that our failure to detect any change in endogenous NO formation during exercise was a consequence of our
choice of assays. NO has a very short half-life in physiologic
systems, of 0.1 s to 5 s (13), and labeling studies show that
plasma [NO3
+ NO2
] reflects a large fraction of NO metabolites or adducts in the body (27, 28). Analysis of whole blood
from healthy humans (29) suggests that under normal conditions, 85% of total NO-related compounds consist of free nitrate, nitrite, or both. The remaining NO-related compounds
are either membrane-bound (~ 10%) or exist as S-nitroso
compounds. The vanadium (III)/HCl solution that we used to
convert nitrate to NO will also convert nitrite and S-nitroso proteins in a plasma sample to NO to be measured by chemiluminescence. Our measurement was not likely to have included the small fraction of total NO-related compounds that
are membrane bound (~ 5%), since these S-nitroso compounds were probably eliminated with the precipitated proteins during the deproteinization process (29). However, in
considering the potential role for endogenously produced NO
as a vasodilator in both the systemic and pulmonary circulations during exercise, it may be important to examine these S-nitrosylated protein pools, given that they have bioactivities comparable to that of NO, but much longer half-lives, on the
order of hours (9, 30).
It must also be considered that plasma [NO3
+ NO2
] also
reflects exogenous sources of nitrate, including foods with a
high content of nitrate and/or nitrite. Although this would not
be expected to have an influence on any expected changes in
plasma [NO3
+ NO2
] from basal levels during exercise, we
did instruct our subjects to maintain a nitrate/nitrite restricted
diet before the study, and the plasma NO levels that we found
are in agreement with those reported for fasted humans (31).
However, one remaining potential limitation is that local increases in NO formation in the pulmonary vascular bed and/or
in the exercising muscle may be too small to be detected in
venous blood sampled at a peripheral site.
Implications
Our results demonstrated that the calculated
NO parameter
was a result of increased expiratory airflow rates during exercise, and that any increases in NO production were not detectable in exhaled air. However, this does not necessarily mean
that endogenous NO formation was not enhanced during exercise. The evidence for flow-induced increases in NO production in isolated blood vessels and cultured endothelial cells is
clear (15, 32), suggesting that the increase in CO during exercise would be expected to enhance the synthesis and release of
NO from the endothelium of vessels in the pulmonary circulation and in the working muscle. The potential role of endogenous NO in the pulmonary circulation has been tested by inhibiting NOS in exercising sheep (33). It was shown that the
increase in resting pulmonary vascular tone caused by inhibition of NOS persisted, but was not increased by exercise.
In conclusion, the reported increases in
NO during exercise are due to the effects of increased airflow rates, and do
not reflect augmented vascular and/or epithelial NO formation. The use of term "NO production" in reference to these
increases is highly misleading, particularly when [NO] is measured at varying expiratory airflow rates.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Claudette M. St. Croix, Ph.D., John Rankin Laboratory of Pulmonary Medicine, Department of Preventive Medicine, University of Wisconsin-Madison, 504 N. Walnut Street, Madison, WI 53705. E-mail: cstcroix{at}facstaff.wisc.edu
(Received in original form June 25, 1998 and in revised form November 4, 1998).
Acknowledgments: Supported by Grant R01-15469 from the National Heart, Lung and Blood Institute and in part by a research fellowship from the American Heart Association of Wisconsin (to Dr. St. Croix).
| |
References |
|---|
|
|
|---|
1. Gustafsson, L. E., A. M. Leone, M. G. Persson, N. P. Wiklund, and S. Moncada. 1991. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem. Biophys. Res. Commun. 181: 852-857 [Medline].
2. Bauer, J. A., J. A. Wald, S. Doran, and D. Soda. 1994. Endogenous nitric oxide in expired air: effects of acute exercise in humans. Life Sci. 55: 1903-1909 [Medline].
3.
Chirpaz-Oddou, M. F.,
A. Favre-Juvin,
P. Flore,
J. Eterradossi,
M. Delaire,
F. Grimbert, and
A. Therminarias.
1997.
Nitric oxide response in
exhaled air during an incremental exhaustive exercise.
J. Appl. Physiol.
82:
1311-1318
4. Iwamoto, J., D. R. Pendergast, H. Suzuki, and J. A. Krasney. 1994. Effect of graded exercise on nitric oxide in expired air in humans. Respir. Physiol. 97: 333-345 [Medline].
5.
Maroun, M. J.,
S. Mehta,
R. Turcotte,
M. G. Cosio, and
S. N. A. Hussain.
1995.
Effects of physical conditioning on endogenous nitric oxide output during exercise.
J. Appl. Physiol.
79:
1219-1225
6. Persson, M. G., N. P. Wiklund, and L. E. Gustafsson. 1993. Endogenous nitric oxide in single exhalations and the change during exercise. Am. Rev. Respir. Dis. 148: 1210-1214 [Medline].
7.
Phillips, C. R.,
G. D. Giraud, and
W. E. Holden.
1996.
Exhaled nitric oxide during exercise: site of release and modulation by ventilation and
blood flow.
J. Appl. Physiol.
80:
1865-1871
8.
Jungersten, L.,
A. Ambring,
B. Wall, and
Å. Wennmalm.
1997.
Both
physical fitness and acute exercise regulate nitric oxide formation in
healthy humans.
J. Appl. Physiol.
82:
760-764
9. Jia, L., C. Bonaventura, J. Bonaventura, and J. S. Stamler. 1996. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 380: 221-226 [Medline].
10. Silkoff, P. E., P. A. McClean, A. S. Slutsky, H. G. Furlott, E. Hoffstein, S. Wakita, K. R. Chapman, J. P. Szalai, and N. Zamel. 1997. Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide. Am. J. Respir. Crit. Care Med. 155: 260-267 [Abstract].
11. Yates, D. H., S. A. Kharitonov, P. S. Thomas, and P. J. Barnes. 1996. Endogenous nitric oxide is decreased in asthmatic patients by an inhibitor of inducible nitric oxide synthase. Am. J. Respir. Crit. Care Med. 154: 247-250 [Abstract].
12.
Spriestersbach, R.,
F. Grimminger,
N. Weissmann,
D. Walmrath, and
W. Seeger.
1995.
On-line measurement of nitric oxide generation in
buffer-perfused rabbit lungs.
J. Appl. Physiol.
78:
1502-1508
13. Gaston, B., J. M. Drazen, J. Loscalzo, and J. S. Stamler. 1994. The biology of nitrogen oxides in the airways. Am. J. Respir. Crit. Care Med. 149: 538-551 [Abstract].
14.
Riley, M. S.,
J. Pórszász,
J. Miranda,
M. P. K. J. Engelen,
B. Brundage, and
K. Wasserman.
1997.
Exhaled nitric oxide during exercise in primary pulmonary hypertension and pulmonary fibrosis.
Chest
111:
44-50
15.
Rubanyi, G. M.,
J. C. Romero, and
P. M. Vanhoutte.
1986.
Flow-induced
release of endothelium-derived relaxing factor.
Am. J. Physiol.
250:
H1145-H1149
16. Pogliaghi, S., J. A. Krasney, and D. R. Pendergast. 1997. Effect of gravity on lung exhaled nitric oxide at rest and during exercise. Respir. Physiol. 107: 157-164 [Medline].
17.
Hyde, R. W.,
E. J. Geigel,
A. J. Olszowka,
J. A. Krasney,
R. E. Forster II,
M. J. Utell, and
M. W. Frampton.
1997.
Determination of production of nitric oxide by lower airways of humans
theory.
J. Appl.
Physiol.
82:
1290-1296
18.
Massaro, A. F., and
J. M. Drazen.
1996.
Invited editorial on "Exhaled nitric oxide during exercise: site of release and modulation by ventilation and blood flow."
J. Appl. Physiol.
80:
1863-1864
19.
Marshall, B. E.,
C. Marshall,
M. Magno,
P. Lilagan, and
G. G. Pietra.
1991.
Influence of bronchial arterial PO2 on pulmonary vascular resistance.
J. Appl. Physiol.
70:
405-415
20. Högman, M., N. Drca, A. Eriksson, R. Kingstad, and J. Henriksson. 1998. Exhaled nitric oxide (NO) levels in elite runners are increased but decreases shortly after competition (abstract). Am. J. Respir. Crit. Care Med. 157: A770 .
21.
Tsoukias, N. M.,
Z. Tannous,
A. F. Wilson, and
S. C. George.
1998.
Single-exhalation profiles of NO and CO2 in humans: effect of dynamically changing flow rate.
J. Appl. Physiol.
85:
642-652
22. Kobzik, L., M. B. Reid, D. S. Bredt, and J. S. Stamler. 1994. Nitric oxide in skeletal muscle. Nature 372: 546-548 [Medline].
23.
Joyner, M. J., and
N. M. Dietz.
1997.
Nitric oxide and vasodilation in human limbs.
J. Appl. Physiol.
83:
1785-1796
24. Komiyama, Y., Y. Kimura, N. Nishimura, K. Hara, T. Mori, K. Okuda, M. Munakata, M. Masuda, T. Murakami, and H. Takahashi. 1997. Vasopressor effects of exercise are accompanied by reduced circulating ouabainlike immunoreactivity and normalization of nitric oxide synthesis. Clin. Exp. Hypertens. 19: 363-372 .
25. Poveda, J. J., A. Riestra, E. Salas, M. L. Cagigas, C. López-Somoza, J. A. Amado, and J. R. Berrazueta. 1997. Contribution of nitric oxide to exercise-induced changes in healthy volunteers: effects of acute exercise and long-term physical training. Eur. J. Clin. Invest. 27: 967-971 [Medline].
26. Node, K., M. Kitakaze, H. Sato, Y. Koretsune, Y. Katsube, M. Karita, H. Kosaka, and M. Hori. 1997. Effect of acute dynamic exercise on circulating plasma nitric oxide level and correlation to norepinephrine release in normal subjects. Am. J. Cardiol. 79: 526-528 [Medline].
27. Rhodes, P. M., A. M. Leone, P. L. Francis, A. D. Struthers, and S. Moncada. 1995. The L-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biochem. Biophys. Res. Commun. 209: 590-596 [Medline].
28. Westfelt, U. N., G. Benthin, S. Lundin, O. Stenqvist, and Å. Wennmalm. 1995. Conversion of inhaled nitric oxide to nitrate in man. Br. J. Pharmacol. 114: 1621-1624 [Medline].
29. Sonada, M., J. Kobayasyi, M. Takezawa, T. Miyazaki, T. Nakajima, H. Shimomura, K. Koike, A. Satomi, H. Ogino, R. Omoto, and T. Komoda. 1997. An assay method for nitric oxide-related compounds in whole blood. Anal. Biochem. 247: 417-427 [Medline].
30.
Stamler, J. S.,
O. Jaraki,
J. Osborne,
D. I. Simon,
J. Keany,
J. Vita,
D. Singel,
C. R. Valeri, and
J. Loscalzo.
1997.
Nitric oxide circulates in
mammalian plasma primarily as an S-nitroso adduct of serm albumin.
Proc. Natl. Acad. Sci. U.S.A.
89:
7674-7677
31. Jungersten, L., A. Edlund, A.-S. Petersson, and Å. Wennmalm. 1996. Plasma nitrate as an index of nitric oxide formation in man: analyses of kinetics and confounding factors. Clin. Physiol. 16: 369-379 [Medline].
32.
Martin, C. M.,
A. Beltran, and
-del-Rio, A. Albrecht, R. R. Lorenz, and M. J. Joyner.
1996.
Local cholinergic mechanisms and mediate nitric oxide-dependent flow-induced vasorelaxation in vitro.
Am. J. Physiol.
270:
H442-H446
33. Koizumi, T., R. Gupta, M. Banerjee, and J. H. Newman. 1994. Changes in pulmonary vascular tone during exercise: effects of nitric oxide (NO) synthase inhibition, L-arginine infusion, and NO inhalation. J. Clin. Invest. 94: 2275-2282 .
This article has been cited by other articles:
![]() |
H.-W. Shin, C. D. Schwindt, A. S. Aledia, C. M. Rose-Gottron, J. K. Larson, R. L. Newcomb, D. M. Cooper, and S. C. George Exercise-induced bronchoconstriction alters airway nitric oxide exchange in a pattern distinct from spirometry Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1741 - R1748. [Abstract] [Full Text] [PDF] |
||||
![]() |
ATS Workshop Proceedings: Exhaled Nitric Oxide and Nitric Oxide Oxidative Metabolism in Exhaled Breath Condensate. Proceedings of the ATS, January 1, 2006; 3(2): 131 - 145. [Full Text] [PDF] |
||||
![]() |
E. West, M. Skowronski, A. C. MS, and E. R. McFadden Jr The Effects of Hyperpnea on Exhaled Nitric Oxide Synthesis in Normal Subjects Chest, November 1, 2005; 128(5): 3316 - 3321. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Haverkamp, J. A. Dempsey, J. D. Miller, L. M. Romer, D. F. Pegelow, J. R. Rodman, and M. W. Eldridge Gas exchange during exercise in habitually active asthmatic subjects J Appl Physiol, November 1, 2005; 99(5): 1938 - 1950. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Adams, J. Bassuk, D. Wu, M. Grana, P. Kurlansky, and M. A. Sackner Periodic acceleration: effects on vasoactive, fibrinolytic, and coagulation factors J Appl Physiol, March 1, 2005; 98(3): 1083 - 1090. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Adachi, S. Oshima, S. Sakurai, T. Toyama, H. Hoshizaki, K. Taniguchi, and H. Ito Nitric oxide exhalation correlates with ventilatory response to exercise in patients with heart disease Eur J Heart Fail, October 1, 2003; 5(5): 639 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Hare, G. C. Nguyen, A. F. Massaro, J. M. Drazen, L. W. Stevenson, W. S. Colucci, J. C. Fang, W. Johnson, M. M. Givertz, and C. Lucas Exhaled nitric oxide: a marker of pulmonary hemodynamics in heart failure J. Am. Coll. Cardiol., September 18, 2002; 40(6): 1114 - 1119. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Wetter, Z. Xiang, D. A. Sonetti, H. C. Haverkamp, A. J. Rice, A. A. Abbasi, K. C. Meyer, and J. A. Dempsey Role of lung inflammatory mediators as a cause of exercise-induced arterial hypoxemia in young athletes J Appl Physiol, July 1, 2002; 93(1): 116 - 126. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. TERADA, T. FUJISAWA, K. TOGASHI, T. MIYAZAKI, H. KATSUMATA, J. ATSUTA, K. IGUCHI, H. KAMIYA, and H. TOGARI Exhaled Nitric Oxide Decreases during Exercise-induced Bronchoconstriction in Children with Asthma Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1879 - 1884. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Bonsignore, G. Morici, L. Riccobono, G. Insalaco, A. Bonanno, M. Profita, A. Paterno, C. Vassalle, A. Mirabella, and A. M. Vignola Airway inflammation in nonasthmatic amateur runners Am J Physiol Lung Cell Mol Physiol, September 1, 2001; 281(3): L668 - L676. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Wetter, C. M. St. Croix, D. F. Pegelow, D. A. Sonetti, and J. A. Dempsey Effects of exhaustive endurance exercise on pulmonary gas exchange and airway function in women J Appl Physiol, August 1, 2001; 91(2): 847 - 858. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. E. Suman and K. C. Beck Role of nitric oxide during hyperventilation-induced bronchoconstriction in the guinea pig J Appl Physiol, April 1, 2001; 90(4): 1474 - 1480. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. F. M. De Gouw, S. J. Marshall-Partridge, H. Van der Veen, J. G. Van den Aardweg, P. S. Hiemstra, and P. J. Sterk Role of nitric oxide in the airway response to exercise in healthy and asthmatic subjects J Appl Physiol, February 1, 2001; 90(2): 586 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Clini, L. Bianchi, M. Vitacca, R. Porta, K. Foglio, and N. Ambrosino Exhaled Nitric Oxide and Exercise in Stable COPD Patients Chest, March 1, 2000; 117(3): 702 - 707. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |